The link between Roaccutane, a brand name of the anti-acne drug isotretinoin, and depression is now under close scrutiny after 10 cases of suicide by people taking the drug were reported in 2019. Some of the families left behind by the suicide victims have already blamed the drug over the years as the culprit behind the deaths of their loved ones.
Based on data from the Medicines and Healthcare Products Regulatory Agency (MHRA), 12 deaths linked to the use of Roaccutane have already been reported for 2019. Among the 12 fatalities, 10 of the victims died by committing suicide, according to The Guardian.
The number of deaths reportedly related to the use of isotretinoin in 2019 is alarming since only five fatalities were reported in 2018. This year’s number of fatalities is the highest on record since the agency began collecting data in 1983.
MHRA data also revealed that aside from the 12 deaths, there were other incidents reported, which are broken down into 19 non-serious cases and 85 serious incidents. There have already been 88 reported deaths since the agency began collecting data.
Around 30,000 people in the UK use Roaccutane each year. Meanwhile, prescriptions for isotretinoin rose from 34,283 in 2008 to 69,040 in 2018 based on NHS Digital data.
Studies have not yet found a clear or direct link to the drug’s usage “with increased risk of psychiatric disorders and suicide.” However, the drug’s 1998 patient information leaflet warned of depression and other psychiatric side-effects.
“Some people have had thoughts about hurting themselves or ending their own lives (suicidal thoughts), have tried to end their own lives (attempted suicide), or have ended their lives (suicide),” the warning stated. “These people may not appear to be depressed.”
“We were never told that these random suicide impulses can come out of the blue and be overwhelming,” said Helen Wright, the mother of 15-year-old Annable Wright who took her own life this year. The victim’s parents are blaming Roaccutane for the tragedy, Channel 4 reported.
The parents of Luke Reeves, who died in 2017, are also blaming the drug for their son’s death. His father, Robert Reeves, revealed during the hearing at Essex coroner’s court that his son’s personality completely changed since he started the acne medication.
The drug’s manufacturer Roche said that “like most medications, it can have side-effects.” The company recommended that patients need to be carefully monitored especially those who have previous history of depression.
Meanwhile, the issue of safety regarding the use of isotretinoin is under continuous review across Europe. The Isotretinoin Expert Working Group has been reconvened and to asses available data regarding the risk of suicide. Depending on its assessment, further regulatory action might be resorted to.


Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



